Explore more publications!

American Financial Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.

Press releases published on October 25, 2025

Affordable Living Trust Preparation Services Now Available Across California
Berry Releases Price Analysis and Forecast for BTC, ETH, XRP, and DOGE Amid Market Shifts
#1 Texas Local Medicare Agent Doubles Client Base Amid 2026 Medicare Part D Disruptions
RockToken Leads Digital Investment Awareness as JPMorgan Adopts Bitcoin Collateral
ROSEN, A LEADING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX
LFMD 2-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Missacc Announces Exclusive Halloween Week Promotion - 15% Discount on All Event Dresses
JASPER CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Jasper Therapeutics Stockholders to Contact the Firm Regarding Filed Class Action
FORTINET CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Fortinet Stockholders to Contact the Firm Before November 21st
Author Suzanne Wylde Releases Her Book - For a New Mom
RCI HOSPITALITY CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds RCI Stockholders of the Filed Class Action Lawsuit and Urges Investors to Contact the Firm Before November 20th
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4’s Path to First- Patient Dosing
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing…
Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025
Bittam Launches $3,000 New User Reward Program No funding fee No slippage and Expands 200× Leverage Trading
CYTOKINETICS CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Cytokinetics Investors of the Filed Class Action Lawsuit and Urges Investors to Contact the Firm Before November 17th
Sify reports Consolidated Financial Results for Q2 FY 2025-26
MoonBull ($MOBU) Announces Stage 5 Presale Milestone at $0.00006584 and Expanding Community Participation

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions